Predictive Model to Calculate the Risk of RBC Transfusion in Elective Brain Tumours Resections (TScoreBTR)

NCT05832450 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1434

Last updated 2024-12-13

No results posted yet for this study

Summary

To validate a predictive model for the risk of receiving RBCs in this population. This model uses four preoperative values (haemoglobin levels, tumour volume, previous craniotomy in the same spot, and number of craniotomies foreseen). The investigators would like to create an online data collection tool and calculator.

Conditions

  • Brain Tumor Adult
  • Transfusion
  • Surgery

Interventions

OTHER

Red cell concentrate transfusion

Perioperative data of patient undergoing elective brain tumor resection with requirements of red cell concentrate transfusion.

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    collaborator OTHER
  • University of Salamanca

    collaborator OTHER
  • Hospital de Leon

    collaborator OTHER_GOV
  • Parc Taulí Hospital Universitari

    collaborator OTHER
  • Hospital de Cruces

    collaborator OTHER
  • Hospital del Mar

    collaborator OTHER
  • Hospital Universitario Marqués de Valdecilla

    collaborator OTHER
  • Hospital Universitario Central de Asturias

    collaborator OTHER
  • Hospital Son Espases

    collaborator OTHER
  • Hospital Universitario Virgen de la Arrixaca

    collaborator OTHER
  • Hospital General Universitario de Valencia

    collaborator OTHER
  • Hospital Universitari de Bellvitge

    collaborator OTHER
  • Hospital Miguel Servet

    collaborator OTHER
  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Principal Investigators

  • Martinez-Simon Antonio, PhD, MD · Department of Perioperative Medicine and Intensive Care

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-21
Primary Completion
2024-02-29
Completion
2024-02-29

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05832450 on ClinicalTrials.gov